Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taniyama, H.
Right arrow Articles by Taya, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniyama, H.
Right arrow Articles by Taya, K.
Vet Pathol 38:661-666 (2001)
© 2001 American College of Veterinary Pathologists

Immunohistochemical Detection of Inhibin-{alpha}, -ßB, and -ßA Chains and 3ß-hydroxysteroid Dehydrogenase in Canine Testicular Tumors and Normal Testes

H. Taniyama, K. Hirayama, K. Nakada, K. Numagami, N. Yaosaka, Y. Kagawa, Y. Izumisawa, T. Nakade, Y. Tanaka, G. Watanabe and K. Taya

Departments of Veterinary Pathology (HT, KH, KN, NY, YK), Veterinary Obstetrics and Gynecology (KN), and Veterinary Surgery (YI, TN), School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan; and Laboratory of Veterinary Physiology, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan (YT, GW, KT)


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Immunohistochemical detection of inhibin-{alpha}, -ßA and -ßB chains and 3ß-hydroxysteroid dehydrogenase (HSD) was carried out on primary testicular tumors from 15 dogs and normal testes from three adult dogs. Histopathologically, the tumors were composed of three types: Leydig cell tumors in five dogs, Sertoli cell tumors in five dogs, and seminoma in five dogs. In normal testes, immunostaining against inhibin-{alpha}, -ßA, and -ßB chains and 3ß-HSD revealed positive reactivity in the cytoplasm of Leydig cells. In testicular tumors, immunoreactive cells against inhibin-{alpha}, -ßA, and -ßB chains and 3ß-HSD were localized in all Leydig cell tumors but not in any Sertoli cell tumors or seminomas. The results of radioimmunoassay for plasma inhibin in dogs with Leydig cell tumors showed higher concentrations than those in dogs with Sertoli cell tumors and seminomas and those in normal dogs. The concentration of inhibin in the plasma was markedly decreased by the surgical removal of the Leydig cell tumor in one dog. Our findings suggest that inhibin is synthesized by normal and neoplastic Leydig cells in the canine testis, and the secreted inhibin may be inhibin A and inhibin B.


Key words: Dogs; immunohistochemistry; inhibin; testis; tumor.

Inhibin is a gonadal hormone that selectively inhibits the secretion of follicle-stimulating hormone (FSH) from the pituitary gland. Inhibin consists of an {alpha}-subunit linked by a disulfide bridge to one of two highly homologous ß-subunits to form either inhibin A ({alpha}-ßA) or inhibin B ({alpha}-ßB). Although inhibin and activin are closely related peptides, activin is composed of homodimers or heterodimers of the same ß-subunits, resulting in activin-A (ßA-ßA), activin-AB (ßA-ßB), or activin-B (ßB-ßB).1,7 Inhibin is secreted from the granulosa cells of ovarian follicles, corpus luteum, and placenta in females2 and presumably from the Sertoli cells in males of humans and rats11,16,17 but not from the Leydig cells in horses.13,14 3ß-Hydroxysteroid dehydrogenase (3ß-HSD), a steroidogenic enzyme, in the normal equine testis is localized only in the Leydig cells and not in the Sertoli cells and germ cells.13 However, the secreting cells of inhibin and 3ß-HSD in canine testes remain unidentified.

Primary testicular tumors are very common in dogs. The three main types are derived from three specialized testicular elements: the interstitial cells of Leydig, the sustentacular cells of Sertoli, and the spermatic germinal epithelium.15 The tumors occur mostly in mature and old dogs, and the incidence of Leydig cell tumors in particular increases with age.15 Previous studies in humans and animals have produced conflicting data on the pattern of expression of the inhibin subunits in normal testes13,14,17–19 and have yielded little information on expression of the inhibin subunits in primary testicular tumors.3,4,6,10 The purpose of the present study was to investigate the secreting cells of inhibin in primary testicular tumors and normal adult testes in dogs.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Tissue preparation

Tissue samples were collected from 15 testicular tumors, including five Leydig cell tumors, five Sertoli cell tumors, and five seminomas, and from three normal testes for control (Table 1). All testicular tumors and normal testes were in the bursula testium and were surgically excised for treatment and castration. Tumor and normal tissues were fixed in 4% phosphate-buffered paraformaldehyde solution, embedded in paraffin, and cut at 4 µm for histopathologic and immunohistochemical examinations. Sections for histopathologic examination were stained with hematoxylin and eosin (HE).


View this table:
[in this window]
[in a new window]
 
Table 1. Results of immunohistochemical examinations of canine tissues for inhibin types and 3ß-HSD.

 
Immunohistochemistry

After deparaffinization, sections were autoclaved for 15 minutes at 121 C in sodium citrate buffer (0.01 M, pH 6.0). The sections were incubated in 3% H2O2-methanol for 30 minutes to quench endogenous peroxidase activity and then washed three times for 5 minutes each in 0.05 M Tris HCl (pH 7.6, with 0.15 M NaCl). Sections were incubated with Block Ace (Dainippon Pharmaceutical Co., Osaka, Japan) at 37 C in a moisture chamber for 30 minutes to prevent nonspecific reactions. The specific antisera used in the present study were 1:500 anti-porcine-[Tyr30]-inhibin-{alpha} (1–30) chain (Dr. N. Ling, Neuroendocrine Inc., San Diego, CA), 1:200 anti-porcine-cyclic inhibin-ßA (81113) (305-24-D) and 1:500 anti-human-cyclic inhibin-ßB (80112) (305-25-D) chains (Dr. W. Vale, Salk Institute for Biological Studies, La Jolla, CA), and 1:500 anti-human-3ß-HSD (Dr. J. I. Mason, Cecil H. and Ida Green Center for Reproductive Science, University of Texas, Southern Medical Center, Dallas, TX) rabbit polyclonal antibodies. Sections were incubated with the primary antibodies at 4 C in a moisture chamber for 6 hours. After washing with Tris HCl buffer, sections were further incubated with 0.5% biotinylated goat anti-rabbit secondary antibody (ABC-peroxidase staining kit Elite, Vector Laboratories, Burlingame, CA) diluted with 0.05 M Tris HCl containing 10% Block Ace for 1 hour at 37 C. The sections were then washed with 0.05 M Tris HCl three times for 5 minutes each and treated with 2% avidin–biotin complex for 30 minutes at 37 C. Sections were then reacted with 0.5% 3,3'-diaminobenzidine tetrachloride (Sigma Chemical Co., St. Louis, MO) and 0.01% H2O2 to visualize the bound antibody. Control sections were exposed to normal rabbit serum (diluted 1:4,000) instead of inhibin antibody at 37 C overnight.

Radioimmunoassay for plasma inhibin

Concentrations of ir-inhibin in canine plasma were measured using a rabbit antiserum against purified bovine inhibin and 125I-labeled 32-kd bovine inhibin, as described previously.8 Plasma samples were corrected from normal dogs (2/3) and prior to surgery from dogs with Leydig cell tumors (5/5), Sertoli cell tumors (3/5), and seminomas (3/5) (Table 1). In one dog with a Leydig cell tumor, a plasma sample was also collected after surgical excision of the tumor. The results were expressed in terms of 32-kd bovine inhibin. The sensitivity of the assay was 7.8 pg/tube (78 pg/ml). The intraassay coefficients of variation were 8.0%. All data were presented as means ± SEM. Student's t-test was used to compare the evaluations of concentration of plasma inhibin in four groups composed of dogs with Leydig cell tumors, Sertoli cell tumors, seminomas, and normal testes. All difference with values of P < 0.05 were considered significant.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Testicular tumors were classified according to the World Health Organization recommendation.9 Leydig cell tumors were classified into three patterns: solid diffuse type, pseudoadenomatous type (Fig. 1), and cystic-vascular type. Sertoli cell tumors were classified into tubular and diffuse type. Cytoplasm of tumor cells in seminoma was scant and slightly acidophilic. The nuclei were variable in size, round, and hyperchromatic. Mitotic figures were very common. In all normal testes, spermatocytogenesis was seen in the seminiferous tubules. The interstitial cells of Leydig formed well-vascularized groups of polyhedral cells, which occupied the spaces between the seminiferous tubules.



View larger version (123K):
[in this window]
[in a new window]
 
Fig. 1. Leydig cell tumor; dog. Pseudoadenomatous pattern consists of the neoplastic cells, which are columnar in shape and have abundant cytoplasm, showing an acidophilic and coarsely vacuolated appearance. HE. Bar = 50 µm.
Fig. 2. Leydig cell tumor; dog. Cytoplasm of the neoplastic cells in pseudoadenomatous tumor shows positive reactivity with anti-porcine inhibin-{alpha} chain antibody. ABC complex method, Mayer's hematoxylin counterstain. Bar = 25 µm.
Fig. 3. Leydig cell tumor; dog. Cytoplasm of the neoplastic cells shows positive reactivity with antihuman inhibin-ßB chain antibody. ABC complex method, Mayer's hematoxylin counterstain. Bar = 25 µm.
Fig. 4. Leydig cell tumor; dog. Cytoplasm of the neoplastic cells shows positive reactivity with anti-porcine inhibin-ßA chain antibody. ABC complex method, Mayer's hematoxylin counterstain. Bar = 25 µm.
Fig. 5. Normal testis; dog. Interstitial cells of Leydig show strong reactivity with anti-porcine inhibin-{alpha} chain antibody. ABC complex method, Mayer's hematoxylin counterstain. Bar = 25 µm.
Fig. 6. Normal testis; dog. Interstitial cells of Leydig show strong reactivity with anti-human inhibin-ßB chain antibody. ABC complex method, Mayer's hematoxylin counterstain. Bar = 25 µm.
Fig. 7. Normal testis; dog. Interstitial cells of Leydig show strong reactivity with anti-porcine inhibin-ßA chain antibody. ABC complex method, Mayer's hematoxylin counterstain. Bar = 25 µm.
Fig. 8. Normal testis; dog. Interstitial cells of Leydig show strong reactivity with anti-human 3ß-HSD antibody. ABC complex method, Mayer's hematoxylin counterstain. Bar = 25 µm.

 
Immunohistochemistry

The results of immunohistochemical examination of inhibin-{alpha}, -ßA, and -ßB chains and 3ß-HSD in testicular tumors and normal testes are summarized in Table 1.

Leydig cell tumors. The cytoplasm of all neoplastic cells, regardless of their histologic tumor patterns, showed immunohistochemical positive reactivity against anti-inhibin-{alpha} (Fig. 2), anti-inhibin-ßA (Fig. 3), and anti-inhibin-ßB (Fig. 4) chains and anti-3ß-HSD antibodies. The reactivity varied in intensity within individual cells, without regard to their morphologic characteristics.

Sertoli cell tumors. Neoplastic Sertoli cells did not react to anti-inhibin-{alpha}, -ßA, and -ßB chains or 3ß-HSD antibodies.

Seminoma. Neoplastic cells in all seminomas showed no immunohistochemical reactivity for any antibodies.

Control testis. The interstitial cells of Leydig were positively stained with anti-inhibin-{alpha} (Fig. 5), -ßA (Fig. 6), and -ßB (Fig. 7) chains and with 3ß-HSD (Fig. 8) antibodies. In seminiferous tubules, Sertoli cells and spermatogenic cells were not stained with any antibodies.

Concentrations of plasma inhibin

The results of radioimmunoassay for plasma inhibin are summarized in Fig. 9. Leydig cell tumors had a higher concentration of ir-inhibin than did Sertoli cell tumors and seminomas and normal testes. Differences in plasma concentration of ir-inhibin were significant (P < 0.05) between the Leydig cell tumor group and the other three groups (Fig. 10). In one dog, the concentration of ir-inhibin in the plasma was markedly decreased by surgical excision of the Leydig cell tumor (Fig. 9).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 9. Results of radioimmunoassay for plasma inhibin of dogs. Concentrations of inhibin in Leydig cell tumor (columns L1–L5) are higher than those in Sertoli cell tumor (columns Sr1–Sr3) and seminoma (columns Se1–Se3) and control dogs (columns C1 and C2). The concentration of inhibin in the plasma is markedly decreased after surgical removal of the Leydig cell tumor in one dog (columns L1-1 and L1-2).

 


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 10. There are significant (P < 0.05) changes in plasma concentration of inhibin between Leydig cell tumor (column L) and Sertoli cell tumor (column Sr), seminoma (column Se), and control dogs (column C).

 

    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
In the human fetal testis, both inhibin-{alpha} and -ßB chains were immunodetectable in Sertoli and Leydig cells at early gestation; however, the immunostaining was stronger in Sertoli cells than in Leydig cells at midgestation.12,16,19 Inhibin in the human adult testis is mainly synthesized by Sertoli cells, with small amounts produced also in the Leydig cells.12,19 In the rat testis, the majority of inhibin-{alpha} and -ßB subunits are immunolocalized to the fetal-type Leydig cells during fetal and neonatal life, but following birth, immunoexpression in the Sertoli cells of both subunits increases markedly.17 One research group reported an absence of immunostaining for the ßA-subunit in human or rat testes.5 Immunoreactive inhibin-{alpha}, -ßA, and -ßB subunits have been reported present in multiple cells in the testes of fetal, neonatal, and adult rats, and amounts of immunostainable subunits in the seminiferous epithelium are differentially regulated.18 In the stallion, immunostaining against inhibin-{alpha} and -ßB subunits revealed strong reactivity in the cytoplasm of Leydig cells and a weak reaction in Sertoli cells in the seminiferous tubules.13,14 Immunoreactivity against the ßA-subunit was also detectable in both types of cells.13,14 3ß-HSD is localized only in the Leydig cells and not in the Sertoli cells and germ cells.13 However, localization of inhibin in canine testes has not been reliably detected. In one study, inhibin was localized in the adult testis by a immunoperoxidase technique using specific antiserum to human testicular inhibin.5 Expression of inhibin was localized in the Sertoli cells, spermatogenia, and primary spermatocytes of dog testis. However, weak positive immunoreactivity indicating the presence of inhibin was also found in Leydig cells.6 In the present study, inhibin was localized in normal canine testes to the interstitial Leydig cells, as in horses,13,14 a different location than that observed in adult humans and rats.12 The coexpression of inhibin-{alpha}, -ßA, and -ßB subunits in the canine interstitial cells of Leydig is consistent with the secretion of both inhibin A and inhibin B, as is the case in horses.13 Furthermore, 3ß-HSD was localized only in the Leydig cells. These findings suggest that inhibin is mainly synthesized in Leydig cells in adult canine testes.

Although little is known about the cells secreting inhibin in primary testicular tumors of humans and the older animals,3,6,10 inhibin immunoreactivity has been biochemically estimated in human and canine gonadal tumors. Sertoli cell tumors in dogs and Leydig cell tumors in humans contained high concentrations of inhibin-like material.3 Inhibin-{alpha} was usually demonstrated in the human Leydig cell tumors and occasionally in the Sertoli cell tumors by immunohistochemical techniques.10 Peripheral levels of immunoassayable inhibin in dogs with Sertoli cell tumors were higher than those in normal dogs.6 Furthermore, such tumors contained increased levels of inhibin and mRNA for the inhibin-{alpha} and -ß subunits as compared with normal testes. The mRNA for the inhibin-ßA subunit was not detected in tumors and testes of normal dogs. Thus, secretory products from Sertoli cell tumors were thought to be inhibin B.6 In rat primary testicular tumors, Leydig cell tumors secreted immunoreactive and bioactive inhibin, which could be immunoneutralized by an antibody against inhibin subunits.4 However, these reports did not include histologic and immunohistochemical studies. Therefore, the cells secreting inhibin subunits in human, canine, and rat primary testicular tumors remain unclear.

In the present study, immunohistochemical expressions of inhibin-{alpha}, -ßA, and -ßB subunits were detected in Leydig cell tumors but not in any Sertoli cell tumors or seminomas. 3ß-HSD was localized only in the Leydig cell tumors. The immunohistochemical findings differ from the results of previous studies3,5,6 because of the different methods of analysis used. Results of radioimmunoassay for plasma inhibin concentration suggest that inhibin is secreted from the neoplastic interstitial cells of Leydig because plasma concentrations of inhibin in dogs with Leydig cell tumors were significantly higher than those in dogs with Sertoli cell tumors or seminomas, and in one dog, the level of inhibin was markedly decreased by the removal of the Leydig cell tumor.

Immunohistochemical expression of inhibin-{alpha}, -ßA, -ßB subunits and 3ß-HSD was localized in the interstitial cells of Leydig of normal testes and of Leydig cell tumors. This finding is supported by the result of radioimmunoassay for plasma inhibin. Inhibin in the adult canine testis is mainly synthesized by Leydig cells and may be inhibin A and inhibin B. 3ß-HSD should be a useful marker to distinguish Leydig cell tumors from other tumors in canine testis.


    Acknowledgments
 
We thank Dr. N. Ling for donating the inhibin-{alpha} chain, Dr. W. Vale for donating the anti-inhibin-ßA chain and anti-inhibin-ßB chain, and Dr. J. I. Mason for donating anti-3ß-HSD antibodies. This study was supported in part by a Grant-in-Aid for Scientific Research (No. 10839014) from of the Ministry of Education, Science and Culture, Japan.


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Burger HG: Inhibin: definition and nomenclature, including related substances. J Endocrinol 117:159-160, 1988[Medline]
  2. De Jong FH: Inhibin. Physiol Rev 68:555-607, 1988[Abstract/Free Full Text]
  3. De Jong FH, Grootenhuis AJ, Steenbergen J, Sluus FJ, Foekens JA, ten Kate FJW, Oosterhuis JW, Lamberts SWJ, Klun JGM: Inhibin immunoreactivity in gonadal and non-gonadal tumors. J Steroid Biochem Mol Biol 17:863-866, 1990
  4. De Winter JP, Timmerman MA, Vanderstichele HM, Klaij IA, Grootenhuis AJ, Rommerts FF, de Jong FH: Testicular Leydig cells in vitro secrete only inhibin alpha-subunits, whereas Leydig cell tumor can secrete bioactive inhibin. Mol Cell Endocrinol 83:105-115, 1992[CrossRef][Medline]
  5. Garde SV, Moodbidri SB, Sheth AR: Localization of inhibin in testes of human, bonnet monkey, dog and rat by immunoperoxidase technique. Indian J Exp Biol 27:404-407, 1989[Medline]
  6. Grootenhuis AJ, Sluijs FJ, Klaij IA, Steenbergen J, Timmerman MA, Bevers MM, Dieleman SJ, de Jong FH: Inhibin gonadotrophins and sex steroids in dogs with Sertoli cell tumors. J Endocrinol 127:235-242, 1990[Abstract]
  7. Halvorson LM, DeCherney AH: Inhibin, activin, and follistatin in reproductive medicine. Fertil Steril 65:459-469, 1996[Medline]
  8. Hamada T, Watanabe G, Kokubo T, Sasamoto S, Hasegawa Y, Miyamoto K, Igarashi M: Radioimmunoassay of inhibin in various mammals. J Endocrinol 122:697-704, 1989[Abstract]
  9. Kennedy PC, Cullen JM, Edwards, Goldschmidt MH, Larsen S, Munson L, Nielsen S: Histological classification of tumors of the genital system of domestic animals. In: WHO International Histological Classification of Tumors of Domestic Animals, ed. Schulman FY, 2nd Series, vol. IV, pp 12-23, Armed Forces Institute of Pathology, Washington, DC 1998
  10. Kommoss F, Oliva E, Bittinger F, Kirkpatrick CJ, Amin MB, Bhan AK, Young RH, Scully RE: Inhibin-alpha, CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome. Hum Pathol 31:105-1061, 2000
  11. Le Gac F, de Kretser DM: Inhibin production by Sertoli cell cultures. Mol Cell Endocrinol 28:487-498, 1982[CrossRef][Medline]
  12. Majdic G, McNeilly AS, Sharpe RM, Evans LR, Groome NP, Saunders TK: Testicular expression of inhibin and active subunits and follistatin in the rat and human fetus and neonate and during postnatal developments in the rat. Endocrinology 138:2136-2147, 1997[Abstract/Free Full Text]
  13. Nagata S, Miyake YI, Nambo Y, Nagamine N, Watanabe G, Tsunoda N, Taniyama H, Hondo E, Yamada J, Taya K: Inhibin secretion in the stallion. Equine Vet J 30:98-103, 1998[Medline]
  14. Nagata S, Tsunoda N, Nagamine N, Tanaka Y, Taniyama H, Nambo Y, Watanabe G, Taya K: Testicular inhibin in the stallion: cellular source and seasonal changes in its secretion. Biol Reprod 59:62-68, 1998[Abstract/Free Full Text]
  15. Nielsen SW, Kennedy PC: Tumors of the genital systems. In: Tumors in Domestic Animals, ed. Moulton JE, 3rd ed., pp 479-513, University of California Press, Berkeley, CA 1990
  16. Rabinovici J, Goldsmith PC, Roberts VJ, Vaughan J, Vale W, Jaffe RB: Localization and secretion of inhibin/activin subunits in the human and subhuman primate fetal gonads. J Clin Endocrinol Metab 73:1141-1149, 1991[Abstract]
  17. Rivier C, Cajander S, Vaughan J, Hsueh AJW, Vale W: Age-dependent changes in physiological action, content, and immunostaining of inhibin in male rats. Endocrinology 123:120-126, 1988[Abstract]
  18. Shaha C, Morris PL, Chen CL, Vale W, Bardin CW: Immunostainable inhibin subunits are in multiple types of testicular cells. Endocrinology 125:1941-1950, 1989[Abstract]
  19. Steinberger A, Steinberger E: Secretion of an FSH-inhibiting factor by cultured Sertoli cells. Endocrinology 99:918-921, 1976[Abstract]
Request reprints from Dr. H. Taniyama, Department of Veterinary Pathology, School of Veterinary Medicine, Rakuno Gakuen University, Bunkyodai-Midorimachi 582, Ebetsu, Hokkaido 069-8501 (Japan).




This article has been cited by other articles:


Home page
Vet PatholHome page
Z. A. Radi, D. L. Miller, and M. E. Hines II
Rete Testis Mucinous Adenocarcinoma in a Dog
Vet. Pathol., January 1, 2004; 41(1): 75 - 78.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taniyama, H.
Right arrow Articles by Taya, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniyama, H.
Right arrow Articles by Taya, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS